Moringa Acquisition Cor-CW26MACAWPreferred / convertible
13F holders, Q4 2025 (December 31)1holders −31
1new positions
0sold out
$0.03avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Moringa Acquisition Cor-CW26 (MACAW) in their 13F filings, down 31 from Q2 2024. 1 opened new positions and 0 sold out. The largest holder was Captrust Financial Advisors ($260).
- Company
- Moringa Acquisition Cor-CW26
- Filed as
- SILEXION THERAPEUTICS CORP WT EXP 081529 (Q4 2025)
- CUSIP
- G6S23K124
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $260 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q4 2025: 10,000 shares bought, net +10,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Captrust Financial Advisors | — | New | 10,000 | $260 |
"% of holder's portfolio" is MACAW's weight in each manager's 13F, not the share of Moringa Acquisition Cor-CW26 the manager owns.